Cognitive sequelae of treatment in childhood acute lymphoblastic leukemia: cranial radiation requires an accomplice
- PMID: 7595698
- DOI: 10.1200/JCO.1995.13.10.2490
Cognitive sequelae of treatment in childhood acute lymphoblastic leukemia: cranial radiation requires an accomplice
Abstract
Purpose: We evaluated cognitive sequelae of treatment for childhood acute lymphoblastic leukemia (ALL). CNS therapy consisted of cranial irradiation (CRT) or no radiation. Children were also randomized to single intravenous high-dose methotrexate (HD-MTX) or conventional-dose methotrexate (CD-MTX) during induction, and all patients received intrathecal (IT) and systemic continuation chemotherapy.
Patients and methods: Sixty-six patients treated for ALL on Dana-Farber Cancer Institute protocol 87-01 were evaluated by standardized cognitive and achievement tests. These children had been assigned at diagnosis to a standard-risk (SR) or high-risk (HR) group and received no CRT or 18 Gy CRT, respectively. All patients were randomized to receive MTX during remission induction, either as CD-MTX (40 mg/m2) or HD-MTX (4 g/m2) with leucovorin rescue.
Results: There was no difference in cognitive outcomes between radiated and unirradiated patients (P > .4). However, the HD-MTX/CRT combination was associated with decreased intelligence quotient (IQ estimate, 9.3 points) for girls only (P < .08). A specific deficit in verbal coding and memory was documented for all patients (P < .0001).
Conclusion: We conclude the following: (1) 18 Gy CRT per se was not an independent toxic agent for cognitive outcome; (2) HD-MTX during induction was associated with IQ decline in girls, but only when it was followed by CRT; and (3) impairment of verbal memory and coding was a consistent finding that was independent of CRT, which implicates some component of chemotherapy, possibly prednisone, as a CNS toxin.
Comment in
-
CNS chemoradiotherapy of childhood leukemia: the plot thickens but the ending bodes well.J Clin Oncol. 1995 Oct;13(10):2480-2. doi: 10.1200/JCO.1995.13.10.2480. J Clin Oncol. 1995. PMID: 7595696 No abstract available.
Similar articles
-
The relationship of sex and treatment modality to neuropsychologic outcome in childhood acute lymphoblastic leukemia.J Clin Oncol. 1992 May;10(5):810-7. doi: 10.1200/JCO.1992.10.5.810. J Clin Oncol. 1992. PMID: 1569453 Clinical Trial.
-
Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.J Clin Oncol. 1995 Oct;13(10):2497-502. doi: 10.1200/JCO.1995.13.10.2497. J Clin Oncol. 1995. PMID: 7595699 Clinical Trial.
-
Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.J Clin Oncol. 2006 Aug 20;24(24):3858-64. doi: 10.1200/JCO.2006.05.9055. J Clin Oncol. 2006. PMID: 16921038
-
[Late sequelae of central nervous system prophylaxis in children with acute lymphoblastic leukemia: high doses of intravenous methotrexate versus radiotherapy of the central nervous system--review of literature].Med Wieku Rozwoj. 2012 Apr-Jun;16(2):128-37. Med Wieku Rozwoj. 2012. PMID: 22971657 Review. Polish.
-
Central nervous system relapse prevention in 1165 standard-risk children with acute lymphoblastic leukemia in five BFM trials.Haematol Blood Transfus. 1990;33:500-3. doi: 10.1007/978-3-642-74643-7_90. Haematol Blood Transfus. 1990. PMID: 2182444 Review.
Cited by
-
Glutathione S-transferase M1 and T1 polymorphisms may predict adverse effects after therapy in children with medulloblastoma.Neuro Oncol. 2009 Jun;11(3):292-300. doi: 10.1215/15228517-2008-089. Epub 2008 Oct 24. Neuro Oncol. 2009. PMID: 18952980 Free PMC article.
-
The impact of therapy for childhood acute lymphoblastic leukaemia on intelligence quotients; results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI.J Hematol Oncol. 2011 Oct 13;4:42. doi: 10.1186/1756-8722-4-42. J Hematol Oncol. 2011. PMID: 21996369 Free PMC article. Clinical Trial.
-
Disruption of learning processes by chemotherapeutic agents in childhood survivors of acute lymphoblastic leukemia and preclinical models.J Cancer. 2011;2:292-301. doi: 10.7150/jca.2.292. Epub 2011 May 19. J Cancer. 2011. PMID: 21611110 Free PMC article.
-
Long-term decline in intelligence among adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiation.Blood. 2013 Jul 25;122(4):550-3. doi: 10.1182/blood-2013-03-487744. Epub 2013 Jun 6. Blood. 2013. PMID: 23744583 Free PMC article. Clinical Trial.
-
Cognitive outcome in children and adolescents treated for acute lymphoblastic leukaemia with chemotherapy only.Acta Paediatr. 2009 Jan;98(1):180-6. doi: 10.1111/j.1651-2227.2008.01055.x. Epub 2008 Sep 30. Acta Paediatr. 2009. PMID: 18826490 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous